This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • HIV/AIDS  • Medical Practice, Other  • World Health  • Public Health, Other  • Drug Therapy, Other  • Alert me on articles by topic

Promise and Problems

Harold W. Jaffe, MD, MA

JAMA. 2008;300(5):573-575.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The 21st century has witnessed unprecedented increases in funding for global health, driven mainly by efforts to address the HIV/AIDS epidemic. The US President's Emergency Plan for AIDS Relief (PEPFAR) is the largest single donor, having allocated approximately $13 billion for AIDS prevention, treatment, and care in developing countries and contributed $3 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria since the plan's inception in 2003.¹ For the next 5 years, the president is seeking a $30 billion appropriation for PEPFAR while Congress is proposing to increase the appropriation to $50 billion and add funding for malaria and tuberculosis programs. In contrast, the World Health Organization (WHO) smallpox eradication program, conducted from 1967 through 1979, cost less than $2 billion (adjusted for inflation).²

Funding to provide antiretroviral treatment (ART) for HIV-infected individuals in developing countries is saving lives. The Joint United Nations . . . [Full Text of this Article]

Distortion of Local Priorities

Author Affiliations: Department of Public Health, University of Oxford, Oxford, United Kingdom.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

President's Emergency Plan for AIDS Relief: Health Development at the Crossroads
Gostin
JAMA 2008;300:2046-2048.
FULL TEXT